Acitretin 10 MG Oral Capsule
INDICATIONS AND USAGE Acitretin capsules are indicated for the treatment of severe psoriasis in adults. Because of significant adverse effects associated with its use, acitretin capsules should be prescribed only by those knowledgeable in the systemic use of retinoids. In females of reproductive potential, acitretin capsules should be reserved for non-pregnant patients who are unresponsive to other therapies or whose clinical condition contraindicates the use of other treatments (see boxed CONTRAINDICATIONS AND WARNINGS — acitretin capsules can cause severe birth defects). Most patients experience relapse of psoriasis after discontinuing therapy. Subsequent courses, when clinically indicated, have produced efficacy results similar to the initial course of therapy.
amneal pharmaceuticals of new york llc
CAPSULE WHITE IX 667
Related Pills
Acitretin 25 MG Oral Capsule
amneal pharmaceuticals of new york llc
Acitretin 17.5 MG Oral Capsule
amneal pharmaceuticals of new york llc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
ACITRETIN capsules USP, 10 mg are supplied as white to off-white body and a brown cap, imprinted in black “IX†on the capsule cap and “667†on the capsule body. They are available as follows: Bottles of 30: NDC 0115-1750-08
ACITRETIN capsules USP, 17.5 mg are supplied as yellow to light yellow body and cap, imprinted in black “IX†on the capsule cap and “668†on the capsule body. They are available as follows: Bottles of 30: NDC 0115-1751-08
ACITRETIN capsules USP, 22.5 mg are supplied as brown body and cap, imprinted in black with “IX†on the capsule cap and “698†on the capsule body. They are available as follows: Bottles of 30: NDC 0115-1752-08
ACITRETIN capsules USP, 25 mg are supplied as yellow to light yellow body and a brown cap, imprinted in black “IX†on the capsule cap and “669†on the capsule body. They are available as follows: Bottles of 30: NDC 0115-1753-08 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from light. Avoid exposure to high temperatures and humidity after the bottle is opened.
More pills like CAPSULE IX 667